(Press-News.org) Less than half of England has access to tirzepatide (Mounjaro) through their GP, despite the NHS roll-out of the weight-loss jab officially starting over two months ago, an investigation by The BMJ has found.
Due to the large number of people who could benefit from tirzepatide - an estimated 3.4 million people - and the drug’s price, NHS England and its spending watchdog, the National Institute for Health and Care Excellence, agreed the injections would be rolled out in phases over a 12-year period, which commenced on 23 June 2025, explains Elisabeth Mahase. Yet just 18 out of 42 commissioning bodies (43%) across the country confirmed that they have started prescribing tirzepatide in line with this roll-out plan.
The data, obtained through Freedom of Information requests, also shows that despite NHS England stating that it expects 70% of eligible patients to come forward for treatment, just nine Integrated Care Boards (ICBs) - responsible for planning health services for their local population - confirmed they have been allocated enough NHS funding to cover at least 70% of their eligible patients.
Experts are warning that the lack of funding and poor communication to the public about the roll-out are driving “distress and uncertainty both in patients and primary care” and have left ICBs in a difficult financial situation.
Of the 40 ICBs that responded to The BMJ’s request, four reported that the NHS funding they had received covers just 25% or less of their eligible patients, with Coventry and Warwickshire faring the worst at 21% of its patients.
And five ICBs have said they are already considering further tightening the tirzepatide prescribing criteria or rationing the treatment beyond this 12-year phased plan.
Birmingham and Solihull ICB says it received funding to cover just 52% of its eligible patients, and said: “Difficult decisions are having to be made to ensure money is spent in the most effective and efficient way possible and for the greatest patient benefit.”
In London just one out of the five ICBs - South West London - has started prescribing tirzepatide, while notices urging patients not to contact their GP as they cannot provide these drugs have been posted by practices around the country, including in Suffolk and North East Essex - where funding for just 25% of eligible patients has been provided.
Tamara Hibbert, chair of Newham Local Medical Committee, says: “While there is significant potential for these drugs to benefit patients, the messaging needs to be clear about what they can expect in terms of the criteria for accessing them on the NHS and the funding available at an ICB level.”
Ellen Welch, Doctors' Association UK (DAUK) co-chair, says: “These figures confirm the fear that the roll out is not fit for purpose. There is a huge discrepancy between national messaging and what patients are actually being delivered on a local level.”
Others warn that the underfunding will have a knock-on effect for the following years, especially as more people will become eligible each year.
Jonathan Hazlehurst at the University of Birmingham, says: “NHS England is talking about treating 220,000 patients in the first three years, but we can see that the initial funding for year one clearly only covers approximately 10% of that.” He also warns that there are patients who would “benefit from really urgent and immediate treatment” with tirzepatide, but are not currently considered a priority.
Nicola Heslehurst, president of the Association for the Study of Obesity, says the deficit in funding compared with need “is another blow for people living with obesity who deserve evidence-based care to manage their health needs,” adding that the current commissioning model has set up a “postcode lottery” of who can access obesity care.
The BMJ contacted NHS England for comment, but received no response at the time of publication.
END
Less than half of England has access to Mounjaro on the NHS months after roll-out
Over 200,000 patients may be eligible for treatment in the first three years, but some commissioners are already considering tighter prescribing criteria or rationing Figures confirm the fear that the roll out is not fit for purpose, says expert
2025-09-04
ELSE PRESS RELEASES FROM THIS DATE:
Study highlights cultural differences in parenting and reveals that how babies are soothed matters more than how fast
2025-09-04
Researchers observed mother–infant interactions in urban UK and rural Ugandan communities, focussing on how mothers soothed their babies following naturally occurring episodes of distress.
They found that although the UK mothers responded to their babies' distress more quickly, Ugandan infants actually recovered faster.
This challenges long-standing assumptions rooted in Western models of parenting by showing that maternal promptness is not the only factor influencing how infants manage ...
Claims on baby food fail to stack up
2025-09-04
From images of fruit to claims of being ‘sugar-free’, baby foods often feature misleading claims aimed at convincing parents the products are a healthy choice, new research shows.
The study led by the University of Auckland, reviewed packaging of more than 200 processed foods for infants and toddlers and found all featured marketing and nutrition claims, which didn’t necessarily stack up when they examined the ingredients. See Nutrition and Dietetics.
“These little packages are cluttered ...
Potential molecular link between air pollutants and increased risk of Lewy body dementia revealed
2025-09-04
September 4, 2025 -- A team of researchers found there is a possible molecular connection between air pollution and an increased risk of developing Lewy body dementia. The study builds on a decade of research linking exposure to fine particulate air pollution (PM2.5) -- from industrial activity, residential burning, wildfires, and vehicle exhaust—to a higher risk of developing these diseases. The findings add to a growing body of evidence indicating how environmental factors may trigger harmful protein changes in the brain that lead to neurodegeneration. The research is published in Science.
Lewy body diseases ...
Deaths from high blood pressure-related kidney disease up nearly 50% in the past 25 years
2025-09-04
Research Highlights:
An analysis of 25 years of the CDC WONDER database for death rates from hypertension-related kidney disease (also called hypertensive kidney disease or hypertensive renal disease) in the U.S. through 2023 found persistent differences across race, ethnicity, gender and region.
The highest death rates for hypertensive kidney disease were among Black individuals, followed by Hispanic individuals.
More men died from hypertensive kidney disease than women, and states in the South had the highest death rates from hypertensive kidney disease.
These findings highlight the urgent ...
U.S. survey finds salt substitutes rarely used by people with high blood pressure
2025-09-04
Research Highlights:
Despite their effectiveness in lowering sodium intake and managing blood pressure, salt substitutes were rarely used by people with high blood pressure, according to a review of almost 20 years of U.S. health survey data.
Researchers recommend increasing awareness of salt substitutes as a strategy to help effectively treat blood pressure, especially for individuals with difficult-to-treat or treatment-resistant high blood pressure.
Note: The study featured in this news release is a research abstract. Abstracts presented ...
Researchers map key human proteins that power coronavirus replication, pointing to new treatment strategies
2025-09-04
LA JOLLA, CA—Despite vaccines and treatments, SARS-CoV-2—the virus that causes COVID-19—continues to pose a global health threat, driven by new variants and its ability to hijack human cells in ways that still aren’t fully understood. Now, scientists at Scripps Research have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
Published in PLOS Biology on June 12, 2025, these findings could open ...
Single hair strand could provide biomarker for ALS, Mount Sinai study finds
2025-09-04
New York, NY (September 4, 2025) – Researchers at the Icahn School of Medicine at Mount Sinai have shown for the first time that a single strand of hair can reveal unique elemental patterns that distinguish people with amyotrophic lateral sclerosis (ALS) from healthy individuals. The findings, published in eBioMedicine, suggest that a simple, non-invasive hair-based test could one day speed ALS diagnosis and improve patient care.
ALS is a progressive and fatal neurodegenerative disease, typically taking 10 to 16 months from symptom onset to diagnosis in the United States. ...
Bio-oil made with corn stalks, wood debris could plug orphaned fossil fuel wells
2025-09-04
AMES, Iowa – Filling abandoned oil and gas wells with bio-oil made from plant-based leftovers like corn stalks and forest debris could help remove carbon dioxide from the atmosphere, returning carbon underground in deep shafts once used to extract it.
The emerging practice, the focus of a recent study by an Iowa State University research team led by mechanical engineering professor Mark Mba-Wright, has a two-birds-one-stone appeal. Unwanted organic matter collected from forests and fields helps sequester carbon in long-term storage while also reducing the emissions and safety risks posed by the hundreds of ...
Can the 'good' bacteria in your mouth act as probiotic cavity fighters?
2025-09-04
If Wenjun Zhang has her way, no one will ever have to brush or floss again.
Zhang, a UC Berkeley professor of chemical and biomolecular engineering, is trying to distinguish the healthy bacteria in our mouths from the unhealthy bacteria — those that cause cavities — so that she can boost the proportion of the former and promote a probiotic oral microbiome.
Our mouth’s microbiome consists of hundreds of different species of bacteria, many of which form a community that sticks to teeth to form plaque. Previous studies have focused on which of those species are associated with cavities, producing acid that eats ...
This common fish has an uncommon feature: Forehead teeth, used for mating
2025-09-04
When it comes to teeth, vertebrates have a lot in common. No matter the shape, size or sharpness, teeth share genetic origins, physical characteristics and, of course, a home in the jaw.
New findings call into question one of these core assumptions. Spotted ratfish, a shark-like species native to the northeastern Pacific Ocean, have rows of teeth on top of their heads, lining a cartilaginous appendage called the tenaculum that loosely resembles Squidward’s nose.
Researchers have long speculated about the origins of teeth — structures so vital to survival and evolution that most of us rarely stop to think about ...
LAST 30 PRESS RELEASES:
Hiring in high-growth firms: new study explores the timing of organizational changes
Boosting work engagement through a simple smartphone diary
Climate change may create ‘ecological trap’ for species who can’t adapt
Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date
AI and omics unlock personalized drugs and RNA therapies for heart disease
2023 ocean heatwave ‘unprecedented but not unexpected’
Johns Hopkins researchers develop AI to predict risk of US car crashes
New drug combination offers hope for men with advanced prostate cancer
New discovery finds gene converts insulin-producing cells into blood-sugar boosters
Powerful and precise multi-color lasers now fit on a single chip
Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing
DNA nanospring measures cellular motor power
Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research
Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates
Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches
Catching Alport syndrome through universal age-3 urine screening
Instructions help you remember something better than emotions or a good night’s sleep
Solar energy is now the world’s cheapest source of power, a Surrey study finds
Scientists reverse Alzheimer’s in mice using nanoparticles
‘Good’ gut bacteria boosts placenta for healthier pregnancy
USC team demonstrates first optical device based on “optical thermodynamics”
Microplastics found to change gut microbiome in first human-sample study
Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds
Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields
Yeast proteins reveal the secrets of drought resistance
Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition
New Canadian study reveals where HIV hides in different parts of the body
Lidocaine poisonings rise despite overall drop in local anesthetic toxicity
Politics follow you on the road
Scientists blaze new path to fighting viral diseases
[Press-News.org] Less than half of England has access to Mounjaro on the NHS months after roll-outOver 200,000 patients may be eligible for treatment in the first three years, but some commissioners are already considering tighter prescribing criteria or rationing Figures confirm the fear that the roll out is not fit for purpose, says expert